A shortage of an immune-disorder treatment has forced hospitals to ration. “I understand the situation, but I’m definitely not looking forward to going back to having more pain.”
The medicine, immune globulin, contains antibodies harvested from plasma, a component of blood.
The injected product helps people with compromised immune systems fight off infections, and treats certain muscle and nerve disorders. The drug’s shortage increases the risk of infection for patients and the amount of pain they are suffering, doctors say.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
FDA backs Gilead's HIV prevention drug for certain populationFDA advisory panel on Wednesday votes in favor of Gilead's combination drug to reduce the risk of sexually acquired HIV infection in men and transgender women who have sex with men.
Read more »
FDA: Pricey Drug Approved on Manipulated DataApproval for a drug meant to treat children with a severe form of spinal muscular atrophy -- which costs over $2 million for a single treatment -- was based on manipulated data provided by the drug's maker, the FDA reports.
Read more »
FDA panel backs Gilead's HIV prevention drug Descovy, except in womenAn FDA advisory panel on Wednesday voted in favor of Gilead Sciences Inc's ...
Read more »
Bausch Health CEO: Big Pharma will survive US drug regulationsPharmaceuticals are 'the most cost effective way' to treat and improve health care, Bausch Health Chariman and CEO Joseph Papa says.
Read more »
Killer Mike reflects on Trump, Baltimore, ‘drug war reparations’ and Bernie SandersAs marijuana becomes increasingly legal throughout the U.S. for recreational and medicinal purposes, Killer Mike says black Americans deserve their fair share of the industry as reparations for the war on drugs.
Read more »
Can Canadian imports lower U.S. drug prices?A new proposal from the Trump administration could allow Americans to import cheaper prescription drugs from Canada. Is this a solution to steep drug costs in the U.S.?
Read more »